Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Marianna Bruno"'
Autor:
Joshua D Mitchell, Daniel J Lenihan, Casey Reed, Ahsan Huda, Kim Nolen, Marianna Bruno, Thomas Kannampallil
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 16 (2022)
Background: Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is a frequently under-recognized cause of heart failure (HF) in older patients. To improve identification of patients at risk for the disease, we initiated a pilot program in which
Externí odkaz:
https://doaj.org/article/fd0c68aa6c42427f83924fa560348e3c
Autor:
Ahsan Huda, Adam Castaño, Anindita Niyogi, Jennifer Schumacher, Michelle Stewart, Marianna Bruno, Mo Hu, Faraz S. Ahmad, Rahul C. Deo, Sanjiv J. Shah
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Transthyretin amyloid cardiomyopathy is a treatable but often unrecognized cause of heart failure. We derived and validated a machine learning model based on medical diagnostic codes that identifies heart failure patients at risk for wild-type transt
Externí odkaz:
https://doaj.org/article/9df90401b120477884a567e3e9520657
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:530-540
Autor:
Rahul Bhambri, A. Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir, Anuja Roy, Jason Kemner, Aaron Crowley, Darrin Benjumea, Lauren Gilstrap
Publikováno v:
American Journal of Cardiovascular Drugs. 23:197-206
Autor:
Marianna Bruno, Daniel P. Judge, Sandi See Tai, Jeffery W. Kelly, Marla B. Sultan, Steve Riley, Adam Castaño, Arianna Burton, Jennifer Schumacher, Jignesh Patel
Publikováno v:
Drug Design, Development and Therapy
Rare diseases are increasingly recognized as a global public health priority. Governments worldwide currently provide important incentives to stimulate the discovery and development of orphan drugs for the treatment of these conditions, but substanti
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Publikováno v:
Heart Failure Reviews
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease characterized by deposition of insoluble amyloid fibrils in the myocardium, resulting in cardiac structural and functional abnormalities and ultimately heart fa
Autor:
Connor Willis, Alexandre H Watanabe, Justin Hughes, Kimberly Nolen, Jason O'Meara, Alexander Schepart, Marianna Bruno, Joseph Biskupiak, Kensaku Kawamoto, Nawar Shara, Thomas Kannampallil
Publikováno v:
Future cardiology. 18(5)
Aim: Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is frequently misdiagnosed, and delayed diagnosis is associated with substantial morbidity and mortality. At three large academic medical centers, combinations of phenotypic features wer
Autor:
Joshua D Mitchell, Daniel J Lenihan, Casey Reed, Ahsan Huda, Kim Nolen, Marianna Bruno, Thomas Kannampallil
Publikováno v:
Clinical Medicine Insights. Cardiology. 16
Background: Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is a frequently under-recognized cause of heart failure (HF) in older patients. To improve identification of patients at risk for the disease, we initiated a pilot program in which
Autor:
Brian Murphy, Matthew Reynolds, Qian Li, Nick Marchant, Peter W. Park, Marianna Bruno, Surbhi Shah, Lauren J Lee, Birol Emir
Publikováno v:
Advances in Therapy
Introduction Varenicline (VAR) is an effective smoking-cessation therapy compared to the commonly used nicotine-replacement therapy patch (NRT-P). However, comparative real-world evidence on smoking-cessation therapies is limited, especially for econ
Autor:
Rahul Bhambri, Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir, Anuja Roy, jason kemner, Aaron Crowley, Darrin Benjumea, Lauren Gray Gilstrap
Publikováno v:
Journal of the American College of Cardiology. 79:558